U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
RESLIZUMAB
DASH   INN   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)
Common Name English
reslizumab [INN]
Common Name English
Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer
Common Name English
RESLIZUMAB [MI]
Common Name English
CEP-38072
Code English
DCP-835
Code English
SCH55700
Code English
RESLIZUMAB [USAN]
Common Name English
CINQAIR
Brand Name English
Reslizumab [WHO-DD]
Common Name English
RESLIZUMAB [PURPLE BOOK CDER]
Common Name English
SCH-55700
Code English
DCP 835
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 328510
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
FDA ORPHAN DRUG 237507
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
NDF-RT N0000191872
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
WHO-ATC R03DX08
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
NCI_THESAURUS C29712
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C152197
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
USAN
LL-65
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
DRUG CENTRAL
5093
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
DRUG BANK
DB06602
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
INN
8106
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
RXCUI
1746889
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
EVMPD
SUB96120
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
FDA UNII
35A26E427H
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
DAILYMED
35A26E427H
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
SMS_ID
100000141689
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
MERCK INDEX
m9543
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY Merck Index
CAS
241473-69-8
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
LACTMED
Reslizumab
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
ChEMBL
CHEMBL2107884
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY
NDF-RT
N0000191871
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY Interleukin-5 Antagonists [MoA]
WIKIPEDIA
RESLIZUMAB
Created by admin on Sat Dec 16 17:48:27 UTC 2023 , Edited by admin on Sat Dec 16 17:48:27 UTC 2023
PRIMARY